Array Drug Misses Study Goal

Shares of Array BioPharma Inc. tumbled in premarket trading Friday after the drugmaker said its experimental rheumatoid arthritis treatment didn’t prove more effective than a placebo in reducing symptoms in a midstage study.
CNBC